<DOC>
	<DOCNO>NCT02951390</DOCNO>
	<brief_summary>Adenomas Lynch syndrome accelerate progression colorectal cancer ( CRC ) might occur despite regular follow-up . Despite low evidence , high-definition technology ( HD ) indigo-carmine chromoendoscopy ( CE ) recommend surveillance Lynch syndrome.The investigator conduct prospective multicenter randomize non-inferiority study . The principal aim compare adenoma detection rate WLE v CE . Our hypothesis HD-white-light endoscopy ( WLE ) inferior CE . Therefore - expert hand - HD-CE add significant advantage HD-WLE adenoma detection rate patient Lynch syndrome .</brief_summary>
	<brief_title>High Definition White-Light Colonoscopy vs. Chromoendoscopy Surveillance Lynch Syndrome .</brief_title>
	<detailed_description>The investigator conduct prospective multicenter randomize non-inferiority study . Eligible patient Lynch syndrome ( know germline mutation mismatch repair gene ) undergo surveillance colonoscopy . Patients sequentially assign 1:1 ratio HD-WLE HD-CE . The method stratify randomization base partial colectomy history use avoid proportion imbalance group . Participant center must organize high-risk CRC clinic endoscopic unit provide HD technology . Endoscopists must document high adenoma detection rate experience perform CE patient high-risk condition CRC . The principal aim compare adenoma detection rate WLE v CE . Principal outcome measure : 1 ) adenoma detection rate , define proportion patient least one adenoma arm ; 2 ) number adenomas per patient , define total number detect adenomas arm ( HD-WLE HD-CE ) divide number colonoscopy arm . The sample size calculation determine non-inferiority study . Assuming ADR 28 % conventional chromoendoscopy patient Lynch syndrome , 15 % non-inferiority margin , one-sided significance level 0.05 power 80 % 10 % drop-off . Based assumption , determine 122 patient require arm ( total 244 ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Colorectal Neoplasms , Hereditary Nonpolyposis</mesh_term>
	<criteria>Patients proven pathologic germline mutation one mismatchrepair ( MMR ) gene ( MLH1 , MSH2 , MSH6 , PMS2 Epcam ) undergo surveillance colonoscopy Patients total colectomy Concomitant inflammatory bowel disease Inadequate bowel preparation ( Boston scale &lt; 2 colonic segment ) Incomplete procedure ( without intubation cecum ileocolonic anastomosis ) Previous colonoscopy less one year Inability sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Surveillance</keyword>
	<keyword>Colorectal cancer</keyword>
	<keyword>Colonoscopy</keyword>
	<keyword>Adenoma</keyword>
	<keyword>Chromoendoscopy</keyword>
</DOC>